These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28818157)

  • 21. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RECIST 1.1-Update and clarification: From the RECIST committee.
    Schwartz LH; Litière S; de Vries E; Ford R; Gwyther S; Mandrekar S; Shankar L; Bogaerts J; Chen A; Dancey J; Hayes W; Hodi FS; Hoekstra OS; Huang EP; Lin N; Liu Y; Therasse P; Wolchok JD; Seymour L
    Eur J Cancer; 2016 Jul; 62():132-7. PubMed ID: 27189322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of lymph nodes with RECIST 1.1.
    Schwartz LH; Bogaerts J; Ford R; Shankar L; Therasse P; Gwyther S; Eisenhauer EA
    Eur J Cancer; 2009 Jan; 45(2):261-7. PubMed ID: 19091550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging response assessment in oncology.
    Curran SD; Muellner AU; Schwartz LH
    Cancer Imaging; 2006 Oct; 6(Spec No A):S126-30. PubMed ID: 17114065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New guidelines to evaluate the response to treatment "RECIST"].
    Sasaki T
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2179-84. PubMed ID: 11142160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on criteria for assessing tumor response to treatment.
    Cruite I; Osman S; Dighe M
    Curr Probl Diagn Radiol; 2013; 42(5):209-19. PubMed ID: 24070714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal lesion number for evaluation of tumor response in response evaluation criteria in solid tumors.
    Rosen MA; Sullivan D
    J Clin Oncol; 2010 Apr; 28(10):e159-60; author reply e161. PubMed ID: 20159810
    [No Abstract]   [Full Text] [Related]  

  • 28. [Measurement of tumour response to cancer treatment: morphologic imaging role].
    Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
    Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site qualification in multicenter clinical trials.
    McEwan AS; Graham MM; Conti PS
    J Nucl Med; 2009 Aug; 50(8):30N. PubMed ID: 19652215
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence-based radiology and the ACR Appropriateness Criteria.
    Blackmore CC; Medina LS
    J Am Coll Radiol; 2006 Jul; 3(7):505-9. PubMed ID: 17412113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttreatment evaluation of central nervous system gliomas.
    Shiroishi MS; Booker MT; Agarwal M; Jain N; Naghi I; Lerner A; Law M
    Magn Reson Imaging Clin N Am; 2013 May; 21(2):241-68. PubMed ID: 23642552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response.
    Warr D; McKinney S; Tannock I
    J Clin Oncol; 1984 Sep; 2(9):1040-6. PubMed ID: 6206206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
    Nishino M; Jagannathan JP; Ramaiya NH; Van den Abbeele AD
    AJR Am J Roentgenol; 2010 Aug; 195(2):281-9. PubMed ID: 20651182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New guidelines for evaluating the therapeutic response of solid tumors: try them!].
    Négrier S
    Bull Cancer; 2000 Dec; 87(12):869-70. PubMed ID: 11174114
    [No Abstract]   [Full Text] [Related]  

  • 35. Imaging techniques for the diagnosis of hepatocellular carcinoma and the evaluation of response to treatment.
    Hussain HK; Barr DC; Wald C
    Semin Liver Dis; 2014 Nov; 34(4):398-414. PubMed ID: 25369302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring health-related quality of life in clinical trials in cystic fibrosis.
    Abbott J; Hart A; Havermans T; Matossian A; Goldbeck L; Barreto C; Bergsten-Brucefors A; Besier T; Catastini P; Lupi F; Staab D
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S82-5. PubMed ID: 21658648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the revised response criteria for acute myelogenous leukemia.
    Cheson BD
    Clin Adv Hematol Oncol; 2004 May; 2(5):277-9. PubMed ID: 16163193
    [No Abstract]   [Full Text] [Related]  

  • 38. A radiologist's guide to treatment response criteria in oncologic imaging: anatomic imaging biomarkers.
    Rezai P; Pisaneschi MJ; Feng C; Yaghmai V
    AJR Am J Roentgenol; 2013 Aug; 201(2):237-45. PubMed ID: 23883205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based radiology: step 3--primary literature validity (critical appraisal).
    Cronin P
    Semin Roentgenol; 2009 Jul; 44(3):153-7. PubMed ID: 19480898
    [No Abstract]   [Full Text] [Related]  

  • 40. Weighty talks about wise choices: a new campaign urges pathologists to be the voice of caution on test orders.
    Nelson B
    Cancer Cytopathol; 2013 Jun; 121(6):277-8. PubMed ID: 23765691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.